Posted in Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA Templates, DNA Testing, Elisa Kits, Enzymes, Exosomes, Gels, Isotypes, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits
A Systematic Review on the Association of Acquired Human Cytomegalovirus Infection with Hearing Loss
Default Cytomegalovirus infection (CMV) induces clinical syndrome which is usually associated with hearing loss. However, the effect of CVM infection obtained in adults and children has not been clearly defined. The purpose of this review is to critically assess the scientific evidence of the Association of CMV infection obtained by postnatal or tinnitus hearing loss. Systematic Overview of Records Reporting Sensorineural Loss (SNHL) or Tinnitus and CMV infection obtained including articles published in English is done.
The search strategy is limited to human studies with CMV infection obtained. After screening and quality assessment, nine studies involving 1528 individuals meet inclusion criteria. A total of 14% of patients with SNHL showed evidence of previous exposure to CMV, while in individuals without SNHL (control) percentage rose to 19.3%. SNHL was reported as unilateral or bilateral at 15.3%, and was not determined in 84.7% of cases. SNHL levels range from mild to deep for children and adults. None of the records reported by Tinitus.
The prevalence of children or adults with SNHL acquired by CMV infection obtained confirmed by polymerase chain reaction (PCR) or low IgM anti-CMV antibodies. Fenotyping of patients with CMV infection obtained is limited to hearing loss with pure tone audiometry and no additional audiological tests carried out in most studies. Additional symptoms deserve more attention, including vertigo episodic or tinnitus, because some patients with the clinical spectrum of meniere disease can result from a latent infection of CMV.
Nitrate oxide flows metabolic regulations mediated by a virus during human cytomegalovirus infection
Nitric Oxide is a multipurpose and critical effector molecule that can modulate many cellular functions. Although it is recognized as a regulator of infection, the inhibition mechanism of nitric oxide on human cytomegalovirus replication (HCMV) is still difficult to understand. We show that nitric oxide weakens viral replication by disrupting modulation mediated by HCMV from several cellular processes.
Nitric oxide exposure reduces the synthesis of HCMV genomes and offspring virus infections with differences depending on the type of cell. Mitochondrial respiration greatly reduced both in infected and infected cells HCMV during exposure with a slight impact at the ATP level which shows changes in cellular metabolism. Metabolomics identifies small molecules that change significantly in several routes during exposure to nitrate oxide including nucleotide biosynthesis, tricarboxylic acid cycles (TCA), and glutamine metabolism. Glutathione metabolites increased to coincide with the reduction of glutamine precursor glutathione.
This shift is accompanied by an increase in antioxidant enzymes. Glutamine deprivation imitated defects in HCMV replication and mitochondrial respiration observed during exposure to nitrate oxide. This data shows that nitric oxide limits glutamineolysis by diverting glutamine to glutathione synthesis. In addition, lipid intermediaries are challenuous, which is likely to contribute to the increase in virus particles observed. Nitric Oxide interferes with several cellular processes, and we have limited success in saving defects replication by adding metabolic intermediaries. Our studies show that the ace of nitrate oxide from HCMV is multifactorial with interference with cellular metabolic viruses that play a central role. The importance of human cytomegalovirus is a common pathogen in patients with a compromised immune system, including transplant patients and during innate infections. Lytic HCMV replication is likely to occur on local infection sites with immune cells that infiltrate and release nitrate oxide with other effector molecules.
The clinical results of the recipients of alogenic hematopoietic stem cell transplants develop DNAEMIA CYTOMEGALOVIRUS before the endraftment
There is limited information about the impact of DNAEMIA CMV episodes that develop before the endraftment (pre-cmv dnaemia) in clinical results after alogenic hematopoietic stem cell transplantation (allo-HSCT). This problem is intended for retrospective multicenter studies currently including 878 patients. All participating centers use the preemptive antivirus therapy strategy for prevention of CMV disease. The load of CMV DNA in the blood is monitored by a real-time PCR test. A total of 144 patients (cumulative events were 16.5%, 95% CI, 14% -19%) had a pre-CMV dnaemia episode on the median 10 days after allo-HSCT.
Patients who develop pre-CMV Dnaemia have a significant probability of recurrent episodes (P = <0.001) (50%) than those who experience post-CMV dnaemia (32.9%); However, the incidence of comparable CMV disease (p = 0.52). The cumulative incidence of the overall death (OM) and non-relapse mortality (NRM) at 1 year after the Allo-HSCT was 32% (95% CI, 29-35%) and 23% (95% CI 20-26%), respectively -Masing. The risk of OM and NRM in a customized model emerged proportion to patients who developed a DNAemia CMV episode, regardless of whether it happened before or after the endraftment, in patients with CMV CMV episodes before and post-engraftment or on those without CMV Dnaemia.
Cytomegalovirus Retinitis After transplantation of alogenic hematopoietic stem cells under the active screening of cytomegalovirus antigenemia
Although Cytomegalovirus (CMV) remains a major cause of morbidity and mortality after transplantation of hematopoietic stem cells (HSCT), the incidence of CMV retinitis is considered lower than the incidence of CMV infection in other organs after the shite. In this study, the incidence and characteristics of CMV retinitis were retrospectively evaluated at the Alogenic HSCT receiver. Eye playback is carried out on the development of ocular symptoms or positive CMV infections using peripheral blood evaluated by antigenemia PP65 or a polymerase chain reaction. Of the 514 patients, 13 patients developed CMV retinitis. The median onset of CMV retinitis is day 34 (range, 21-118) post transplants, and cumulative events are 2.5% (95% CI, 1.6-42) at 6 months after transplantation.
NUMBL Antibody |
E92140 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
NUMBL Antibody |
R36056-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: Numb-like |
NUMBL Antibody |
MBS7108731-005mg |
MyBiosource |
0.05mg |
EUR 190 |
NUMBL Antibody |
MBS7108731-01mg |
MyBiosource |
0.1mg |
EUR 270 |
NUMBL Antibody |
MBS7108731-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
NUMBL antibody |
MBS9406496-005mL |
MyBiosource |
0.05mL |
EUR 300 |
NUMBL antibody |
MBS9406496-01mL |
MyBiosource |
0.1mL |
EUR 390 |
NUMBL antibody |
MBS9406496-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1610 |
NUMBL Antibody |
MBS8516333-01mg |
MyBiosource |
0.1mg |
EUR 305 |
NUMBL Antibody |
MBS8516333-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
NUMBL Antibody |
MBS8516333-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
NUMBL Antibody |
MBS8516333-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
NUMBL Antibody |
MBS8516333-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
NUMBL Antibody |
MBS8504604-01mL |
MyBiosource |
0.1mL |
EUR 325 |
NUMBL Antibody |
MBS8504604-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
NUMBL Antibody |
MBS8504604-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
NUMBL Antibody |
MBS8504604-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
NUMBL Antibody |
MBS8504604-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
NUMBL Antibody |
MBS2522682-006mL |
MyBiosource |
0.06mL |
EUR 230 |
NUMBL Antibody |
MBS2522682-012mL |
MyBiosource |
0.12mL |
EUR 310 |
NUMBL Antibody |
MBS9607516-01mL |
MyBiosource |
0.1mL |
EUR 260 |
NUMBL Antibody |
MBS9607516-02mL |
MyBiosource |
0.2mL |
EUR 305 |
NUMBL Antibody |
MBS9607516-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
NUMBL Antibody |
C45119-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: NUMBL Rabbit Polyclonal Antibody |
NUMBL Antibody |
C45119-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: NUMBL Rabbit Polyclonal Antibody |
anti- NUMBL antibody |
FNab05917 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against NUMBL |
anti- NUMBL antibody |
FNab05918 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against NUMBL |
NUMBL Antibody (C-term) |
MBS9204395-008mL |
MyBiosource |
0.08mL |
EUR 210 |
NUMBL Antibody (C-term) |
MBS9204395-04mL |
MyBiosource |
0.4mL |
EUR 430 |
NUMBL Antibody (C-term) |
MBS9204395-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
NUMBL Antibody, HRP conjugated |
1-CSB-PA897595LB01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against NUMBL. Recognizes NUMBL from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
NUMBL Antibody, HRP conjugated |
MBS7108732-005mg |
MyBiosource |
0.05mg |
EUR 190 |
NUMBL Antibody, HRP conjugated |
MBS7108732-01mg |
MyBiosource |
0.1mg |
EUR 270 |
NUMBL Antibody, HRP conjugated |
MBS7108732-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
NUMBL Antibody, FITC conjugated |
1-CSB-PA897595LC01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against NUMBL. Recognizes NUMBL from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
NUMBL Antibody, FITC conjugated |
MBS7108733-005mg |
MyBiosource |
0.05mg |
EUR 190 |
NUMBL Antibody, FITC conjugated |
MBS7108733-01mg |
MyBiosource |
0.1mg |
EUR 270 |
NUMBL Antibody, FITC conjugated |
MBS7108733-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
NUMBL Antibody, Biotin conjugated |
1-CSB-PA897595LD01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against NUMBL. Recognizes NUMBL from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
NUMBL Antibody, Biotin conjugated |
MBS7108734-005mg |
MyBiosource |
0.05mg |
EUR 190 |
NUMBL Antibody, Biotin conjugated |
MBS7108734-01mg |
MyBiosource |
0.1mg |
EUR 270 |
NUMBL Antibody, Biotin conjugated |
MBS7108734-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
NUMBL Polyclonal Antibody |
A70355 |
EpiGentek |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ?g
- 20 ul
- 50 ul
- 100 ul
|
NUMBL Polyclonal Antibody |
E914088 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
NUMBL Conjugated Antibody |
C38379 |
SAB |
100ul |
EUR 476.4 |
NUMBL Polyclonal Antibody |
MBS127004-002mL |
MyBiosource |
0.02mL |
EUR 200 |
NUMBL Polyclonal Antibody |
MBS127004-005mL |
MyBiosource |
0.05mL |
EUR 255 |
NUMBL Polyclonal Antibody |
MBS127004-01mL |
MyBiosource |
0.1mL |
EUR 345 |
NUMBL Polyclonal Antibody |
MBS127004-02mL |
MyBiosource |
0.2mL |
EUR 545 |
NUMBL Polyclonal Antibody |
MBS127004-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2265 |
NUMBL Polyclonal Antibody |
MBS9234267-01mL |
MyBiosource |
0.1mL |
EUR 415 |
NUMBL Polyclonal Antibody |
MBS9234267-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
NUMBL Polyclonal Antibody |
MBS9134097-002mL |
MyBiosource |
0.02mL |
EUR 200 |
NUMBL Polyclonal Antibody |
MBS9134097-005mL |
MyBiosource |
0.05mL |
EUR 255 |
NUMBL Polyclonal Antibody |
MBS9134097-01mL |
MyBiosource |
0.1mL |
EUR 345 |
NUMBL Polyclonal Antibody |
MBS9134097-02mL |
MyBiosource |
0.2mL |
EUR 545 |
NUMBL Polyclonal Antibody |
MBS9134097-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2265 |
NUMBL Polyclonal Antibody |
MBS8568786-01mL |
MyBiosource |
0.1mL |
EUR 305 |
NUMBL Polyclonal Antibody |
MBS8568786-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
NUMBL Polyclonal Antibody |
MBS8568786-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
NUMBL Polyclonal Antibody |
MBS8568786-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
NUMBL Polyclonal Antibody |
MBS8568786-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
NUMBL Polyclonal Antibody |
MBS2566247-006mL |
MyBiosource |
0.06mL |
EUR 190 |
NUMBL Polyclonal Antibody |
MBS2566247-012mL |
MyBiosource |
0.12mL |
EUR 265 |
NUMBL Polyclonal Antibody |
MBS2566247-02mL |
MyBiosource |
0.2mL |
EUR 415 |
NUMBL Polyclonal Antibody |
MBS2566247-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1835 |
NUMBL Conjugated Antibody |
MBS9448603-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
NUMBL Conjugated Antibody |
MBS9448603-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
NUMBL Conjugated Antibody |
MBS9448603-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
NUMBL Conjugated Antibody |
MBS9448603-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
NUMBL Conjugated Antibody |
MBS9448603-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
NUMBL Polyclonal Antibody |
RD267415A-120uL |
Reddot Biotech |
120μL |
EUR 360 |
|
Description: NUMBL (NUMB Like Endocytic Adaptor Protein) is a Protein Coding gene. Diseases associated with NUMBL include Differentiating Neuroblastoma. Among its related pathways are Notch Signaling Pathway (WikiPathways). An important paralog of this gene is NUMB. |
NUMBL Polyclonal Antibody |
RD267415A-200uL |
Reddot Biotech |
200μL |
EUR 630 |
|
Description: NUMBL (NUMB Like Endocytic Adaptor Protein) is a Protein Coding gene. Diseases associated with NUMBL include Differentiating Neuroblastoma. Among its related pathways are Notch Signaling Pathway (WikiPathways). An important paralog of this gene is NUMB. |
NUMBL Polyclonal Antibody |
RD267415A-60uL |
Reddot Biotech |
60μL |
EUR 204 |
|
Description: NUMBL (NUMB Like Endocytic Adaptor Protein) is a Protein Coding gene. Diseases associated with NUMBL include Differentiating Neuroblastoma. Among its related pathways are Notch Signaling Pathway (WikiPathways). An important paralog of this gene is NUMB. |
Polyclonal NUMBL Antibody (N-Term) |
AMM06872G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NUMBL (N-Term). This antibody is tested and proven to work in the following applications: |
Polyclonal NUMBLIKE / NUMBL Antibody (N-Terminus) |
AMM06873G |
Leading Biology |
0.05ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NUMBLIKE / NUMBL (N-Terminus). This antibody is tested and proven to work in the following applications: |
NUMBL Antibody (C-term) Blocking peptide |
MBS9220443-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx117223-100ug |
Abbexa |
100 ug |
EUR 560.4 |
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
20-abx001752 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx235917-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx235918-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
20-abx334204 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx431475-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx117223-100g |
Abbexa |
100 µg |
EUR 450 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx235917-100g |
Abbexa |
100 µg |
EUR 350 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx235918-100g |
Abbexa |
100 µg |
EUR 350 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx431475-200l |
Abbexa |
200 µl |
EUR 387.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx433691-100g |
Abbexa |
100 µg |
EUR 387.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx334204-100g |
Abbexa |
100 µg |
EUR 362.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx334204-20g |
Abbexa |
20 µg |
EUR 162.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx334204-50g |
Abbexa |
50 µg |
EUR 250 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx001752-100l |
Abbexa |
100 µl |
EUR 387.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx001752-20l |
Abbexa |
20 µl |
EUR 175 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody |
abx001752-50l |
Abbexa |
50 µl |
EUR 275 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (HRP) |
20-abx336868 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (HRP) |
abx336868-100g |
Abbexa |
100 µg |
EUR 362.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (HRP) |
abx336868-20g |
Abbexa |
20 µg |
EUR 162.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (HRP) |
abx336868-50g |
Abbexa |
50 µg |
EUR 250 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (FITC) |
20-abx336869 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (FITC) |
abx336869-100g |
Abbexa |
100 µg |
EUR 362.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (FITC) |
abx336869-20g |
Abbexa |
20 µg |
EUR 162.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (FITC) |
abx336869-50g |
Abbexa |
50 µg |
EUR 250 |
NUMBL Polyclonal Antibody, HRP Conjugated |
A70356 |
EpiGentek |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (Biotin) |
20-abx336870 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (Biotin) |
abx336870-100g |
Abbexa |
100 µg |
EUR 362.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (Biotin) |
abx336870-20g |
Abbexa |
20 µg |
EUR 162.5 |
NUMB Like, Endocytic Adaptor Protein (NUMBL) Antibody (Biotin) |
abx336870-50g |
Abbexa |
50 µg |
EUR 250 |
NUMBL Polyclonal Antibody, FITC Conjugated |
A70357 |
EpiGentek |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
NUMBL Polyclonal Antibody, Biotin Conjugated |
A70358 |
EpiGentek |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
NUMBL |
CSB-CL897595HU |
Cusabio |
10 μg plasmid + 200μl Glycerol |
Ask for price |
Rabbit Anti Human NUMBL PolyClonal Antibody |
MBS1491075-01mL |
MyBiosource |
0.1mL |
EUR 335 |
Rabbit Anti Human NUMBL PolyClonal Antibody |
MBS1491075-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1475 |
NUMBL, CT (NUMBL, Numb-like protein, Numb-related protein) |
MBS649100-02mL |
MyBiosource |
0.2mL |
EUR 695 |
NUMBL, CT (NUMBL, Numb-like protein, Numb-related protein) |
MBS649100-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2975 |
NUMBL siRNA |
20-abx926610 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NUMBL siRNA |
20-abx926611 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NUMBL siRNA |
20-abx903703 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NUMBL Peptide |
43-109P |
ProSci |
0.1 mg |
EUR 405.6 |
NUMBL, CT (NUMBL, Numb-like protein, Numb-related protein) (AP) |
MBS6327216-02mL |
MyBiosource |
0.2mL |
EUR 980 |
NUMBL, CT (NUMBL, Numb-like protein, Numb-related protein) (AP) |
MBS6327216-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
Five patients present ocular symptoms on onset. In eight asymptomatic patients remaining, the diagnosis of CMV retinitis is made by screening guided by a positive CMV infection. All patients can be evaluated responding to antivirus treatment but three shows an increase incomplete with the sequel to ocular. Our results show that the incidence of CMV retinitis after the Alogenic HSCT cannot be ignored and active ophthalmological screening is not only based on symptoms but also monitoring positive CMV infection contributes to early diagnosis of CMV retinitis.